Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Seminoma surgery

Introduction

Overview

Overview

Surgery is the mainstay of treatment for seminoma. The feasibility of surgery depends on the stage of seminoma at diagnosis which include: radical inguinal orchiectomy, retroperitoneal lymph node dissection, salvage surgery and surgery for metastases.

Surgery

Surgery

  • Surgery is usually reserved for majority of patients.The feasibility of surgery depends on the stage of seminomsat diagnosis.[1][2][3]
  • The feasibility of surgery depends on the stage of seminoma at diagnosis.
  • Surgery is the mainstay of treatment for seminoma which include:[4][5][6][7]

Radical Inguinal Orchiectomy

  • Among patients who present with clinically advanced disease, radical orchiectomy is useful to remove the tumor prior to chemotherapy when possible.

Retroperitoneal Lymph Node Dissection

Salvage Surgery

  • Among patient who dose not response to chemotherapy after orchiectomy the surgery used to remove residual disease is called salvage surgery.[9][10]
  • Salvage surgery may include a bilateral RPLND.[11]

Surgery for Metastases

References

References

  1. ↑ Batool A, Karimi N, Wu XN, Chen SR, Liu YX (May 2019). “Testicular germ cell tumor: a comprehensive review”. Cell. Mol. Life Sci. 76 (9): 1713–1727. doi:10.1007/s00018-019-03022-7. PMIDΒ 30671589.
  2. ↑ Boujelbene, Noureddine; Cosinschi, Adrien; Boujelbene, Nadia; Khanfir, Kaouthar; Bhagwati, Shushila; Herrmann, Eveleyn; Mirimanoff, Rene-Olivier; Ozsahin, Mahmut; Zouhair, Abderrahim (2011). “Pure seminoma: A review and update”. Radiation Oncology. 6 (1). doi:10.1186/1748-717X-6-90. ISSNΒ 1748-717X.
  3. ↑ Al-Salem, Ahmed H. (2014). “Testicular Tumors”: 505–511. doi:10.1007/978-3-319-06665-3_64.
  4. ↑ Boujelbene N, Cosinschi A, Boujelbene N, Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M, Zouhair A (August 2011). “Pure seminoma: a review and update”. Radiat Oncol. 6: 90. doi:10.1186/1748-717X-6-90. PMCΒ 3163197. PMIDΒ 21819630.
  5. ↑ Oldenburg J, FossΓ₯ SD, Nuver J, Heidenreich A, Schmoll HJ, Bokemeyer C, Horwich A, Beyer J, Kataja V (October 2013). “Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Ann. Oncol. 24 Suppl 6: vi125–32. doi:10.1093/annonc/mdt304. PMIDΒ 24078656.
  6. ↑ Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J (December 2007). “Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors”. J. Clin. Oncol. 25 (35): 5603–8. doi:10.1200/JCO.2007.13.6283. PMIDΒ 17998544.
  7. ↑ 7.0 7.1 Lavery HJ, Bahnson RR, Sharp DS, Pohar KS (October 2009). “Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors”. Ther Adv Urol. 1 (4): 199–207. doi:10.1177/1756287209350315. PMCΒ 3126061. PMIDΒ 21789067.
  8. ↑ Invalid <ref> tag; no text was provided for refs named pmid29487620
  9. ↑ Surgery for testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/treatment/surgery/?region=on. Accessed on March 2, 2016
  10. ↑ Daneshmand S, Djaladat H, Nichols C (August 2011). “Management of residual mass in nonseminomatous germ cell tumors following chemotherapy”. Ther Adv Urol. 3 (4): 163–71. doi:10.1177/1756287211418721. PMCΒ 3175700. PMIDΒ 21969846.
  11. ↑ Heidenreich A, Pfister D (August 2012). “Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice”. Ther Adv Urol. 4 (4): 187–205. doi:10.1177/1756287212443170. PMCΒ 3398597. PMIDΒ 22852029.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]